drugset / Trial / NCT03460808
The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
NaSingle-groupOpen-labelTreatment
Summary
Single-arm, open-lable, multicentre study to compare the efficacy and safety of atorvastatin, acetylcysteine plus danazol with danazol monotherapy in patients with corticosteroidresistant/relapsed ITP.
Timeline
- Start
- 2018-03-10
- Primary completion
- 2020-01-01
- Completion
- 2023-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 20 mg | Oral |
| Subject | Danazol | Other / unclassified | 200 mg | Oral |
| Subject | N-acetylcysteine | Small molecule | 400 mg | Oral |